HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU REACH, Seventh Amendment Issues Addressed By Lauder Exec

This article was originally published in The Rose Sheet

Executive Summary

A proposed ban on products tested on animals under the EU's Seventh Amendment to the Cosmetics Directive could hinder industry's ability to comply with the EU REACH chemicals program, according to Estee Lauder Senior VP, Global R&D Harvey Gedeon

You may also be interested in...



ECVAM Validates Non-Animal Test Methods For Assessing Cosmetics Safety

The scientific committee of the European Center for the Validation of Alternative Methods has endorsed new safety test methods that reduce or eliminate the use of animals, the European Cosmetic Toiletry and Perfumery Association states in a May 2 release

ECVAM Validates Non-Animal Test Methods For Assessing Cosmetics Safety

The scientific committee of the European Center for the Validation of Alternative Methods has endorsed new safety test methods that reduce or eliminate the use of animals, the European Cosmetic Toiletry and Perfumery Association states in a May 2 release

Industry Braces For Impact Of REACH As Legislation Nears Passage

The European Parliament is set to vote on - and likely pass - the Registration, Evaluation, Authorization & Restriction of Chemicals legislation on Dec. 13, according to industry observers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel